Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 75 6
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 38 47
Quinacrine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/10/2021 3 0
Azithromycin Potential treatment - clinical evidence Used to treat other disease Antiviral Feb/26/2021 19 10
Verteporfin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/09/2020 2 0
Protoporphyrin IX Potential treatment - pre-clinical evidence Natural product Antiviral Dec/09/2020 1 0
Mycophenolic acid Potential treatment - pre-clinical evidence Used to treat other disease Antiviral May/05/2020 3 0
4D5 Potential treatment - pre-clinical evidence Experimental Antiviral May/03/2020 1 0
4A3 Potential treatment - pre-clinical evidence Experimental Antiviral May/03/2020 1 0
4A10 Potential treatment - pre-clinical evidence Experimental Antiviral May/03/2020 1 0
Excel (.xslx) CSV (.csv)